Determinants of the Cancer Drug Funding Process in Canada
Background: Canada has a publicly funded healthcare system with a complex drug funding process. After Health Canada approval to market a drug, the pan-Canadian Oncology Drug Review (pCODR) (now renamed the CADTH reimbursement review) makes a non-binding funding recommendation to the Canadian provinc...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2022-03-01
|
| Schriftenreihe: | Current Oncology |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/1718-7729/29/3/162 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|